Onconova Therapeutics Inc Shares Near 52-Week Low - Market Mover
The shares closed 5.2% above its 52-week low of $2.11, with trading volume lower than its 30 day average
Jan 15, 2022 by Kwhen Finance Editors
Onconova Therapeutics Inc (ONTX) shares closed today at 5.2% above its 52 week low of $2.11, giving the company a market cap of $47M. The stock is currently down 12.9% year-to-date, down 79.3% over the past 12 months, and down 99.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%.
Trading Activity
- Trading volume this week was 51.0% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
- The stock closed at 2.3% lower than its 5-day moving average, 12.1% lower than its 20-day moving average, and 34.5% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Onconova Therapeutics Inc | -0.4 | -12.9 | -79.3 | -92.4 | 4.3 |
| Dow Jones Industrial Average | -0.6 | -1.2 | 17.8 | -3.1 | 22.0 |
| S&P 500 Index | 0.0 | -2.2 | 24.4 | -3.9 | 26.9 |
| Health Care | -0.2 | -5.7 | 12.9 | -6.8 | 19.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 43.2%
- The company's stock price performance over the past 12 months lags the peer average by 74.8%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Onconova Therapeutics Inc | ONTX | 0 | -12.9 | -79.3 | -92.4 | 4.3 |
| Peer Avg | N/A | 6.1 | -9.0 | -45.4 | -53.8 | 19.5 |
| Baxter International Inc. | BAX | 35.4 | -0.1 | 8.6 | -3.7 | 18.0 |
| Array Technologies Inc | ARRY | 0 | -16.6 | -73.0 | -74.6 | 5.3 |
| CTI BioPharma Corp | CTIC | -4.7 | -10.5 | -32.5 | -46.5 | 54.5 |
| Spectrum Pharmaceuticals, Inc. | SPPI | 0 | -11.0 | -70.2 | -75.8 | 4.8 |
| Cyclacel Pharmaceuticals Inc | CYCC | 0 | -6.9 | -59.8 | -68.4 | 14.6 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: